ABSTRACT:Bernard B. Brodie's laboratory was the first to examine the mechanisms of drug-induced toxicity at the molecular level. They found that acetaminophen hepatotoxicity was due to the metabolic activation of the drug to a highly reactive toxic metabolite that depleted cellular glutathione and covalently bound to protein. Subsequent studies revealed that activation of acetaminophen to an active metabolite is primarily carried out by CYP2E1, an ethanolinducible cytochrome P450 that was first suggested by characterization of the microsomal ethanol oxidation system. CYP2E1 is developmentally regulated, under liver-specific control, and undergoes substrate-induced protein stabilization. It is also regulated by starvation and diabetes through insulin-dependent mRNA stabilization. In addition to acetaminophen, CYP2E1 metabolically activates a large number of low M r toxicants and carcinogens and thus is of great toxicological importance. The mechanism of regulation CYP2E1 and its role in acetaminophen toxicity will be discussed.I am delighted and honored to be a recipient of the Bernard B. Brodie award. Like Brodie, I have spent my career at the National Institutes of Health. Other than our mutual interest in xenobiotic metabolism, the similarities end. Brodie was a pioneer in drug metabolism and toxicity and the concepts he generated during the course of his career are still of major importance in the development and use of drugs, and in the fields of dietary and environmental toxicology. Brodie led the transition of the field of classical physiological-based pharmacology into biochemical pharmacology where mechanism of drug action and toxicity could be determined. In particular, he noted that drug-induced toxicities can be due to dose-dependent production of highly reactive and unstable intermediates that covalently bind to cellular macromolecules. These concepts laid the foundations for subsequent studies including the enzymology, purification, and cloning of drug-metabolizing enzymes and, more recently, the production of genetically modified mice that were used to reveal the in vivo role of P450s and other drug-metabolizing enzymes in chemical toxicities. Among the most important P450s involved in chemical toxicities is CYP2E1.
Ethanol-Inducible CYP2E1CYP2E1 has been extensively studied for many years because of its relevance to chemical toxicity and carcinogenicity. It is also conserved in mammals; although there are a number of single nucleotide polymorphisms in the CYP2E1 gene, there are no known polymorphisms that are the result of inactive CYP2E1 genes in humans or any animal models, and there are no large differences in catalytic activity among humans, rabbits, rats, and mice. This suggests that CYP2E1 has an important function in mammals.The Microsomal Ethanol Oxidation System and CYP2E1. The finding that microsomal membrane fractions are capable of catalyzing the oxidation of ethanol, designated the microsomal ethanol-oxidizing system (MEOS), was the first indication of the presence of an ethanol oxidi...